In a first, England's NHS says it will scrape medical histories of 55M patients, including info on mental and sexual health, to be shared with third-parties
55m patients have until June 23 to opt out of having their health data scraped into a new database Tweets: @financialtimes , @foxglovelegal , @foxglovelegal , @we_ownit , and @foxglovelegal Tweets: @financialtimes : One of the concerns raised is that patients only have a few weeks to opt out of the plan. If they miss the cut-off date, their historical records will become a permanent and irreversible part of the new data set https://www.ft.com/... https://twitter.com/... Foxglove / @foxglovelegal : This makes NHS health data of *massive* interest to researchers. So far, so good - we all want the NHS to come out of the pandemic stronger. But there are issues: who gets access? On what terms? Who can patients trust? And who benefits - us, the NHS, or private companies? Foxglove / @foxglovelegal : In many ways, this fight is about the future of the NHS. The NHS sits atop the most valuable trove of health data in the world. Why? For years, your GP record has been stored not in doctor's scrawled notes but using GP codes, which a computer can ‘read’. (h/t @marcus_baw) @we_ownit : Allowing “third parties” access to medical data and patient records is absolutely shocking. This is a clear privatisation of NHS data. It has to be stopped. https://www.ft.com/... Foxglove / @foxglovelegal : ⏰BREAKING: HMG quietly rolled out a scheme to seize - & sell access to - the health data of every man, woman, and child in England. Patients weren't asked. Legal issues? We think so. So we helped @JustTreatment send a legal letter. @madhumita29 in @FT: https://www.ft.com/...
Context & Ripple Effects
NHS England is converting the entire English patient population into a research asset: 55 million medical histories, including mental and sexual health records, pooled for third-party access with an opt-out window closing June 23 — and records of patients who miss it become a permanent, irreversible part of the dataset. The announcement lands on a fraught track record: critics previously called misleading the claim that millions of NHS patient records sold to American drug companies were properly anonymized, and Google's hospital-scale record collection under Project Nightingale drew similar scrutiny over mass medical-data gathering.
First-order effects
- Privacy groups Foxglove, We Own It and Just Treatment are campaigning against the plan on consent grounds, and every adult in England faces a hard choice before June 23: opt out or have historical mental and sexual health records locked permanently into the shared database.
- Third-party recipients — researchers first among them — gain lawful bulk access to one of the world's largest single-payer health datasets, including fields patients never explicitly agreed to release.
Second-order effects
- Commercial demand follows immediately: the earlier sale of NHS-derived data to US drug companies shows the buyer base exists, so the new pool becomes a priced product whose value depends on how many patients opt out before the deadline.
- The scheme hands ammunition to campaigners like Foxglove and We Own It, who can now point to the short opt-out window and irreversible inclusion as proof that consent in national health-data programs is designed around the system, not the patient.
Third-order effects
- The Biobank investigation — where sensitive data of roughly 500K volunteers reached insurance companies despite a public pledge otherwise — previews the structural risk: once a state health body aggregates at national scale, downstream control depends entirely on recipient promises, not technical guarantees.
- If opt-out rates climb as awareness spreads, England's experiment becomes the cautionary case shaping how other national systems design consent — pushing toward explicit opt-in models and harder legal limits on third-party reuse, a tension already visible in the criticism of US app-based record-sharing rules that lacked strong protections.
The trend: National health systems are becoming bulk data suppliers, and whether public trust survives is being decided less by anonymization claims than by who controls consent windows and downstream access.